MFDS — authorised 6 June 2014
- Marketing authorisation holder: DOW PHARM
- Status: likely_approved
🇰🇷 Jublia in South Korea
MFDS authorised Jublia on 6 June 2014
Marketing authorisation
Jublia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Jublia approved in South Korea?
Yes. MFDS authorised it on 6 June 2014.
Who is the marketing authorisation holder for Jublia in South Korea?
DOW PHARM holds the South Korean marketing authorisation.